VRAX

NASD Virax Biolabs Group Ltd. Class A
Oct 1, 2026 · 3:20 PM ET DELAYED Market Open

$2.27 ↑ +0.08 (+3.71%) Trading Up from the previous close of $2.18, $0.11 below the day’s high of $2.37

YTD change
-73.80%
vs 20-day SMA
-9.93%
vs 200-day SMA
-52.42%

Price ranges

Previous day
$2.13 $2.27
open $2.25 close $2.18
-$0.07 (-2.93%)
Today
$2.18 $2.37
open $2.18 now $2.27
+$0.09 (+3.90%)
Past week
$2.04 $2.60
from $2.55 now $2.27
-$0.29 (-11.18%)
Past month
$2.04 $2.92
from $2.60 now $2.27
-$0.34 (-12.88%)
This year
$0.10 $13.19
from $8.65 now $2.27
-$6.38 (-73.80%)

Price & Performance

+1.99 (+1003.03%) / 6M

$-0.3964$2.02$4.44$6.86Apr 1Jul 1Sep 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 100.0% away from all-time highs of $7,250.00
  • VRAX is down 74% since the beginning of the year
  • VRAX is down 85% over the past 12 months
  • VRAX is down 13% over the past 1 month
  • 2% of all VRAX investors are betting against VRAX

VRAX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +252.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-5398590.0
Beta 1.39

Balance sheet & scale

IncomeN/A
Revenue$12.4K
Cash$6.4M
Debt$414.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.1M

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $421.51 -0.50%
MRNA Moderna, Inc. $192.57 -5.35%
RVMD Revolution Medicines, Inc. $205.26 +0.38%
ROIV Roivant Sciences Ltd. $36.57 +0.19%
BNTX BioNTech SE Sponsored ADR $98.30 -0.27%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.